Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Schwann cell differentiation inhibits interferon-gamma induction of expression of major histocompatibility complex class II and intercellular adhesion molecule-1.
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis.
In vitro evaluation of physiologically relevant concentrations of teriflunomide on activation and proliferation of primary rodent microglia.
Vibration Training Improves Disability Status Among Individuals With Multiple Sclerosis: 1477 Board #130 June 2, 9: 00 AM - 10: 30 AM.
Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients.
Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study.
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
Editorial Note to:Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
The "butterfly diagram": A gait marker for neurological and cerebellar impairment in people with multiple sclerosis.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
Corrigendum to "The-effect-of-triiodothyronine-on-maturation-and-differentiation-of-oligodendrocyte-progenitor-cells-during-remyelination-following-induced-demyelination in male albino rat" [Tissue Cell 48 (March (3)) (2016) 242-251].
ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis.
Large amplitude cortical evoked potentials (EPs) in non-epileptic patients. Reviving an old neurophysiologic tool to help detect CNS Pathology.
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
Substrate reduction therapy for Krabbe's disease.
Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.
Epidemiology of Multiple Sclerosis.
The Role of Latently Infected B Cells in CNS Autoimmunity.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation-Reply.
Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis.
Use of natalizumab in multiple sclerosis: current perspectives.
RAE-1 expression is induced during experimental autoimmune encephalomyelitis and is correlated with microglia cell proliferation.
Pages
« first
‹ previous
…
778
779
780
781
782
783
784
785
786
…
next ›
last »